Interaction of Adriamycin and N-Trifluoroacetyladriamycin-14-Valerate with Cardiolipin-Containing Lipid Bilayers
- 1 January 1989
- journal article
- research article
- Published by Taylor & Francis in Journal of Liposome Research
- Vol. 1 (2) , 245-260
- https://doi.org/10.3109/08982108909035995
Abstract
The interaction of adriamycin (ADR) and N-Trifluoroacetyladriamycin-14-valerate (AD 32) with cardiolipin (CL)-containing multilamellar vesicles was studied by high-sensitivity differential scanning calorimetry, using liposomes formed from either dipalmitoylphosphatidylcholine (DPPC) or dipalmitoylphosphatidylglycerol (DPPG) containing small amounts of CL. the drugs partitioned into cardiolipin-containing neutral and acidic bilayers in a manner similar to that observed earlier with CL-free bilayers. the partition coefficient of adriamycin in bilayers of vesicles prepared from DPPG or DPPG in admixture with CL was much higher than that obtained with neutral DPPC vesicles or the DPPC together with CL. Under all conditions, AD 32 was essentially completely partitioned into the lipid phase of the investigated phospholipid membranes. As expected, addition of adriamycin to CL-containing vesicles did not significantly change the thermotropic behavior of these bilayers, whereas the fluidizing effect of AD 32 was directly related to the CL content of the vesicles. the multipeak transitions produced by the anthracyclines in pure DPPG bilayers were preserved in the presence of CL, but the endotherms were broader and slightly shifted to lower temperatures, a finding indicative of stronger interactions. Chlorpromazine (CPZ), which was used as a reference compound to compare the effects produced by the anthracyclines, was found to behave similarly to AD 32 and to be more effective than quinidine (QND), in agreement with their behavior in CL-free liposomes.Keywords
This publication has 23 references indexed in Scilit:
- Interaction of Ca2+ with cardiolipin-containing liposomes and its inhibition by adriamycinBiochemical Pharmacology, 1985
- Anthracycline glycoside-membrane interactionsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1984
- NADH oxidation in submitochondrial particles protects respiratory chain activity against damage by adriamycin‐Fe3+European Journal of Biochemistry, 1983
- The mitochondrial phosphate carrier reconstituted in liposomes is inhibited by doxorubicinFEBS Letters, 1983
- Adriamycin inhibits the formation of non-bilayer lipid structures in cardiolipin-containing model membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1982
- Adriamycin inactivates cytochrome c oxidase by exclusion of the enzyme from its cardiolipin essential environmentBiochemical and Biophysical Research Communications, 1982
- The Anthracycline Antineoplastic DrugsNew England Journal of Medicine, 1981
- Evidence of a complex between adriamycin derivatives and cardiolipin: Possible role in cardiotoxicityBiochemical Pharmacology, 1980
- Cardiolipins: Their Chemistry and BiochemistryProgress in Lipid Research, 1979
- Phospholipid composition of membranes in the tumor cellBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1970